Table 1 Baseline clinicopathologic characteristics of 1773 PTC patients
From: PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis
Mean + SD | Mean + SD | ||
|---|---|---|---|
Age (years) | 42.1 ± 12.4 | Number of CLNMs | 2.6 ± 3.3 |
Size (cm) | 1.5 ± 1.0 | Number of LLNM | 1.7 ± 2.9 |
Sex | CLNMs | ||
Female | 1260 (71.1%) | No | 576 (32.5%) |
Male | 513 (28.9%) | Yes | 1197 (67.5%) |
Age | LLNM | ||
< = 55 | 1289 (84.9%) | No | 948 (53.5%) |
> 55 | 230 (15.1%) | Yes | 825 (46.5%) |
Size (cm) | Level II/III | ||
≤ 1 | 862 (48.6%) | No | 1089 (61.4%) |
1~2 | 624 (35.2%) | Yes | 684 (38.6%) |
> 2 | 287 (16.2%) | Level IV | |
Location | No | 1399 (78.9%) | |
Upper | 624 (35.2%) | Yes | 374 (21.1%) |
Non-upper | 1149 (64.8%) | pNx | |
ETE | pN0 | 437 (24.6%) | |
No | 1398 (78.8%) | pN1 | 1336 (75.4%) |
Yes | 375 (21.2%) | ||
Multifocality | Hashimoto | ||
No | 1461 (82.4%) | No | 1526 (86.1%) |
Yes | 312 (17.6%) | Yes | 247 (13.9%) |